Fuentes, Jonathan B.

HRN: 24-31-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2024
CO-AMOXICLAV 625MG (TAB)
01/02/2024
01/09/2024
PO
625mg
TID
URTI
Waiting Final Action 
01/06/2024
MUPIROCIN 2%, 15G (TUBE)
01/06/2024
01/12/2024
TOPICAL
2%
BID
Open Lesions Both Feet
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: